Short interest in Canntab Therapeutics Ltd (OTC:CTABF) decreased during the last reporting period, falling from 125.00 to 125.00. This put -% of the company's publicly available shares short.

Short interest for Canntab Therapeutics gives investors a sense of the degree to which investors are betting on the decline of Canntab Therapeutics's stock. Short interest data is updated every two weeks.

Based on the recent average volume of - shares traded per day, it would take 999.99 day(s) for holders of this short interest to close out their positions without sending the stock sharply higher.